Minimally Invasive Thoracic Surgery Market Worth $5.3 Billion By 2025: Grand View Research, Inc.

SAN FRANCISCO, December 5, 2017 /PRNewswire/ --

The global minimally invasive thoracic surgery market [ ] is expected to reach USD 5.3 billion by 2025, based on a new report by Grand View Research, Inc. Minimally Invasive Surgery (MIS) is gaining popularity owing to the reduced risk and trauma associated with these procedures as small incisions decrease post-operative pain that facilitates a speedy recovery. Increasing research and development in this field is another high impact rendering driver of the market.

(Logo: )

Introduction of novel technologies and devices by the market players have been observed in the recent years. In 2016, Cardiac received the FDA clearance for its MicroCutter XCHANGE 30 surgical stapling device for resection and transection in minimally invasive and open pediatric, urologic and thoracic surgical procedures.

In the U.S., lung cancer is a second leading cancer form. According to the American Cancer Society, about 222,500 new lung cancer cases are estimated in 2017. A high number of smokers in the U.S. is a leading cause of cancer prevalence in the region.

Smoking is also one of the major risk factors for lung cancer in developing countries. Nearly 80% of the smokers live in middle and low-income countries. This makes developing countries a potential market for thoracic surgeries.

Browse full research report with TOC on "Minimally Invasive Thoracic Surgery Market Analysis By Type (Lobectomy, Wedge Resection, Pneumonectomy, Others), By Region (North America, Europe, Asia Pacific, Latin America, MEA), And Segment Forecasts, 2014 - 2025" at: rket [ ]

Further Key Findings From the Report Suggest: 

        - Lobectomy dominated the market in 2016. Lobectomy procedure involves removal of an
          entire lobe of the lung in cases of stage one non-small cell lung cancer (NSCLC). It
          is preferred over the limited resections as a large portion is removed, thereby
          decreasing the risk of recurrence in the local area.
        - There is a trend of increasing adoption of minimally invasive technique in other types
          of thoracic surgery such as sleeve lobectomy, segmentectomy, and thoracic
          sympathectomy. The factors owing to the growth is the technological advancements,
          better imaging technologies and the introduction of minimally invasive surgical
        - Geographically, North America held the largest market share in 2016 and is expected to
          maintain its position during the forecast period. This region dominated the market on
          account of the high prevalence of the target disorder, high smoking traits in the
          population and the huge funding involved in the research involving solutions to lung
        - Moreover, availability of the technologically advanced surgical methods with better
          surgeon expertise is expected to increase the market growth.
        - Asia-Pacific region shows the fastest growth in the coming years due to rapid adoption
          of technology and growing awareness about the target disorders
        - Some key industry contributors are Medtronic plc, Cardio medical GmbH, Intuitive
          Surgical, Richard Wolf GmbH, Grena Ltd., Dextera Surgical Inc., Teleflex Incorporated,
          Medela Healthcare, LivaNova plc, Sklar Surgical Instruments.

Browse related reports by Grand View Research: 

        - Contrast Media/Contrast Agents Market
        - Acid Citrate Dextrose Tubes Market
        - Surface Analysis Market -

        - Hospital Supplies Market -

Grand View Research has segmented the minimally invasive thoracic surgery market by type and region: 

        - Type Outlook (Market Revenue in USD Million, 2014 - 2025) 
             - Lobectomy
             - Wedge Resection
             - Pneumonectomy
             - Others
        - Regional Outlook (Market Revenue in USD Million, 2014 - 2025) 
             - North America
                - U.S.
                - Canada
             - Europe
                - Germany
                - UK
             - Asia Pacific
                - Japan
                - China
             - Latin America
                - Brazil
                - Mexico
             - Middle East and Africa
                - South Africa

Read Our Blog By Grand View Research:

About Grand View Research 

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.


        Sherry James 
        Corporate Sales Specialist, USA 
        Grand View Research, Inc 
        Phone: +1-415-349-0058 
        Toll Free: 1-888-202-9519 




SOURCE Grand View Research, Inc.